Table 2. Genetic variants in the FGF family associated with two of the three phenotypic traits (height, hypertension, and osteoporosis) or below the Bonferroni-corrected significance level.
Gene | Chr | SNP | Minor allele | MAF | Function | Height | HTN | Osteoporosis | |||
---|---|---|---|---|---|---|---|---|---|---|---|
β ± s.e | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | ||||||
FGF2 | 4 | rs167428 | C | 0.087 | intron | 0.112 ± 0.054 | 0.037 | 1.040 (0.99–1.09) | 0.122 | 1.131 (1.03–1.24) | 8.59 × 10 −3 |
4 | rs308387 | A | 0.052 | intron | 0.234 ± 0.068 | 5.85 × 10 −4 | 1.023 (0.96–1.09) | 0.487 | 1.062 (0.94–1.20) | 0.317 | |
FGF4 | 11 | rs58166091 | A | 0.213 | - | 0.114 ± 0.037 | 2.16 × 10 −3 | 0.989 (0.96–1.02) | 0.544 | 1.026 (0.96–1.10) | 0.436 |
FGF10 | 5 | rs17227836 | C | 0.054 | intron | -0.161 ± 0.067 | 0.016 | 0.993 (0.93–1.06) | 0.816 | 1.144 (1.02–1.28) | 0.021 |
5 | rs13154419 | G | 0.412 | intron | 0.112 ± 0.031 | 2.89 × 10 −4 | 0.991 (0.96–1.02) | 0.545 | 0.988 (0.94–1.04) | 0.674 | |
5 | rs1448039 | A | 0.500 | intron | -0.094 ± 0.030 | 1.90 × 10 −3 | 1.006 (0.98–1.04) | 0.653 | 1.017 (0.96–1.07) | 0.528 | |
FGF18 | 5 | rs10463007 | T | 0.404 | - | 0.081 ± 0.031 | 9.26 × 10 −3 | 0.990 (0.96–1.02) | 0.498 | 1.071 (1.01–1.13) | 0.014 |
FGF22 | 19 | rs8109113 | G | 0.024 | intron | -0.241 ± 0.100 | 0.016 | 0.901(0.82–0.99) | 0.028 | 1.021 (0.85–1.22) | 0.824 |
Age, sex and body mass index (BMI) were included as covariant in all genetic models. Findings with P < 0.05 are indicated in bold. The p-values which satisfied the Bonferroni-corrected significance level regarding each gene are indicated in bold and underlined. Abbreviations: SNP, single nucleotide polymorphism; Chr, chromosome; MAF, minor allele frequency; HTN, hypertension; β, regression coefficient; s.e, standard error; OR, odds ratio; CI, confidence interval.